Clinical Trials: Immunotherapy
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Karen A. Autio, Christopher A. Klebanoff, David Schaer, John Sae Wook Kauh, Susan F. Slovin, Matthew Adamow, Victoria S. Blinder, Manisha Brahmachary, Michelle Carlsen, Elizabeth Comen, Daniel C. Danila, Thompson N. Doman, Jeremy C. Durack, Josef J. Fox, Jill S. Gluskin, David M. Hoffman, Suhyun Kang, Praneet Kang, Jonathan Landa, Philomena F. McAndrew, Shanu Modi, Michael J. Morris, Ruslan Novosiadly, Dana E. Rathkopf, Rachel Sanford, Sonya C. Chapman, Courtney M. Tate, Danni Yu, Phillip Wong and Heather L. McArthur
Karen A. Autio
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Christopher A. Klebanoff
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
3Parker Institute for Cancer Immunotherapy, New York, New York.
David Schaer
4Pfizer WRD, Pearl River, New York.
John Sae Wook Kauh
5Hutchison MediPharma International (US) Inc., Florham Park, New Jersey.
Susan F. Slovin
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Matthew Adamow
1Memorial Sloan Kettering Cancer Center, New York, New York.
Victoria S. Blinder
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Manisha Brahmachary
6Eli Lilly and Company, New York, New York.
Michelle Carlsen
7Eli Lilly and Company, Indianapolis, Indiana.
Elizabeth Comen
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Daniel C. Danila
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Thompson N. Doman
7Eli Lilly and Company, Indianapolis, Indiana.
Jeremy C. Durack
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Josef J. Fox
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Jill S. Gluskin
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
David M. Hoffman
8Cedars-Sinai Medical Center, Los Angeles, California.
Suhyun Kang
7Eli Lilly and Company, Indianapolis, Indiana.
Praneet Kang
1Memorial Sloan Kettering Cancer Center, New York, New York.
Jonathan Landa
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Philomena F. McAndrew
8Cedars-Sinai Medical Center, Los Angeles, California.
Shanu Modi
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Michael J. Morris
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Ruslan Novosiadly
6Eli Lilly and Company, New York, New York.
9Bristol-Myers Squibb, Princeton, New Jersey.
Dana E. Rathkopf
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Rachel Sanford
1Memorial Sloan Kettering Cancer Center, New York, New York.
2Weill Cornell Medical College, New York, New York.
Sonya C. Chapman
10Eli Lilly and Company, Windlesham, United Kingdom.
Courtney M. Tate
7Eli Lilly and Company, Indianapolis, Indiana.
Danni Yu
7Eli Lilly and Company, Indianapolis, Indiana.
Phillip Wong
1Memorial Sloan Kettering Cancer Center, New York, New York.
Heather L. McArthur
8Cedars-Sinai Medical Center, Los Angeles, California.
DOI: 10.1158/1078-0432.CCR-20-0855 Published November 2020

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
November 2020
Volume 26, Issue 21
Volume 26, Issue 21
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Karen A. Autio, Christopher A. Klebanoff, David Schaer, John Sae Wook Kauh, Susan F. Slovin, Matthew Adamow, Victoria S. Blinder, Manisha Brahmachary, Michelle Carlsen, Elizabeth Comen, Daniel C. Danila, Thompson N. Doman, Jeremy C. Durack, Josef J. Fox, Jill S. Gluskin, David M. Hoffman, Suhyun Kang, Praneet Kang, Jonathan Landa, Philomena F. McAndrew, Shanu Modi, Michael J. Morris, Ruslan Novosiadly, Dana E. Rathkopf, Rachel Sanford, Sonya C. Chapman, Courtney M. Tate, Danni Yu, Phillip Wong and Heather L. McArthur
Clin Cancer Res November 1 2020 (26) (21) 5609-5620; DOI: 10.1158/1078-0432.CCR-20-0855
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Karen A. Autio, Christopher A. Klebanoff, David Schaer, John Sae Wook Kauh, Susan F. Slovin, Matthew Adamow, Victoria S. Blinder, Manisha Brahmachary, Michelle Carlsen, Elizabeth Comen, Daniel C. Danila, Thompson N. Doman, Jeremy C. Durack, Josef J. Fox, Jill S. Gluskin, David M. Hoffman, Suhyun Kang, Praneet Kang, Jonathan Landa, Philomena F. McAndrew, Shanu Modi, Michael J. Morris, Ruslan Novosiadly, Dana E. Rathkopf, Rachel Sanford, Sonya C. Chapman, Courtney M. Tate, Danni Yu, Phillip Wong and Heather L. McArthur
Clin Cancer Res November 1 2020 (26) (21) 5609-5620; DOI: 10.1158/1078-0432.CCR-20-0855
Jump to section
Advertisement